Wuhan Easy Diagnosis Biomedicine Co.,Ltd. (SHE:002932)
China
· Delayed Price · Currency is CNY 19.23
+0.01 (0.05%)
May 30, 2025, 10:44 AM CST
SHE:002932 Revenue
In the year 2024, Wuhan Easy Diagnosis Biomedicine had annual revenue of 350.06M CNY, down -53.30%. Wuhan Easy Diagnosis Biomedicine had revenue of 69.96M in the quarter ending March 31, 2025, with 14.76% growth.
Revenue
350.06M
Revenue Growth
-53.30%
P/S Ratio
12.05
Revenue / Employee
329.31K
Employees
1,063
Market Cap
4.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 350.06M | -399.47M | -53.30% |
| Dec 31, 2023 | 749.54M | -9.78B | -92.88% |
| Jan 1, 2023 | 10.53B | 7.70B | 272.12% |
| Jan 1, 2022 | 2.83B | 1.87B | 195.05% |
| Dec 31, 2020 | 959.10M | 777.94M | 429.43% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |